Fascioliasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-02
Clinical Trial Update: Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). [Phase 4]
A Phase 4 clinical trial evaluating the safety, tolerability, and clinical outcomes of Egaten (triclabendazole) in Fascioliasis patients age…